Long-Term Efficacy of Adjunctive Cariprazine in Patients With MDD: Results From an Open-Label 26-Week Safety Study

被引：0

作者：

Masand, Prakash ^{[1
]}

Vieta, Eduard ^{[1
]}

Waraich, Simranpreet ^{[1
]}

Kramer, Ken ^{[1
]}

Kerolous, Majid ^{[1
]}

机构：

[1] AbbVie, New York, NY USA

来源：

NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷

关键词：

Cariprazine; Major Depressive Disorder; Depression; Adjunctive; Long-Term;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

P343

引用

页码：263 / 264

页数：2

共 50 条

[41] Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study
Kudrow, David
Hutchinson, Susan
Pixton, Glenn C.
Fullerton, Terence
PAIN AND THERAPY, 2025, 14 (01) : 237 - 255
[42] Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study
Rogers, SL
Friedhoff, LT
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1998, 8 (01) : 67 - 75
[43] Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study
Ganesh Raghu
Mark J. Hamblin
A. Whitney Brown
Jeffrey A. Golden
Lawrence A. Ho
Marlies S. Wijsenbeek
Martina Vasakova
Alberto Pesci
Danielle E. Antin-Ozerkis
Keith C. Meyer
Michael Kreuter
Tracy Burgess
Nikhil Kamath
Francis Donaldson
Luca Richeldi
Respiratory Research, 23
[44] Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study
Raghu, Ganesh
Hamblin, Mark J.
Brown, A. Whitney
Golden, Jeffrey A.
Ho, Lawrence A.
Wijsenbeek, Marlies S.
Vasakova, Martina
Pesci, Alberto
Antin-Ozerkis, Danielle E.
Meyer, Keith C.
Kreuter, Michael
Burgess, Tracy
Kamath, Nikhil
Donaldson, Francis
Richeldi, Luca
RESPIRATORY RESEARCH, 2022, 23 (01)
[45] Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: An open-label study
Wohlreich M.M.
Mallinckrodt C.H.
Watkin J.G.
Hay D.P.
BMC Geriatrics, 4 (1)
[46] Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease
Hattori, Nobutaka
Takeda, Atsushi
Takeda, Shinichi
Nishimura, Akira
Kitagawa, Tadayuki
Mochizuki, Hideki
Nagai, Masahiro
Takahashi, Ryosuke
JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (03) : 299 - 308
[47] Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease
Nobutaka Hattori
Atsushi Takeda
Shinichi Takeda
Akira Nishimura
Tadayuki Kitagawa
Hideki Mochizuki
Masahiro Nagai
Ryosuke Takahashi
Journal of Neural Transmission, 2019, 126 : 299 - 308
[48] Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
Berman, Robert M.
Thase, Michael E.
Trivedi, Madhukar H.
Hazel, James A.
Marler, Sabrina Vogel
McQuade, Robert D.
Carson, William
Baker, Ross A.
Marcus, Ronald N.
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 303 - 312
[49] Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort
Iborra, Marisa
Ferreiro-Iglesias, Rocio
Dolores, Martin-Arranz Maria
Gismero, Francisco Mesonero
Minguez, Alejandro
Porto-Silva, Sol
Garcia-Ramirez, Laura
de la Filia, Irene Garcia
Aguas, Mariam
Nieto-Garcia, Laura
Ferrer, Cristina Suarez
Bastida, Guillermo
Barreiro-De-Acosta, Manuel
Nos, Pilar
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2024, 59 (03) : 260 - 268
[50] Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study
Zouboulis, Christos C.
Okun, Martin M.
Prens, Errol P.
Gniadecki, Robert
Foley, Peter A.
Lynde, Charles
Weisman, Jamie
Gu, Yihua
Williams, David A.
Jemec, Gregor B. E.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 60 - +

← 1 2 3 4 5 →